Clene (CLNN) EBITDA Margin (2020 - 2025)

Clene has reported EBITDA Margin over the past 6 years, most recently at 11953.25% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 310280.0% year-over-year to 11953.25%; the TTM value through Dec 2025 reached 13036.0%, down 147811.0%, while the annual FY2025 figure was 13036.0%, 147811.0% down from the prior year.
  • EBITDA Margin for Q4 2025 was 11953.25% at Clene, up from 58506.67% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 26233.64% in Q3 2021 and troughed at 58506.67% in Q3 2025.
  • A 5-year average of 11526.48% and a median of 9241.35% in 2023 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: skyrocketed 6284693bps in 2021 and later plummeted -4938828bps in 2025.
  • Year by year, EBITDA Margin stood at 2238.69% in 2021, then plummeted by -118bps to 397.86% in 2022, then plummeted by -1388bps to 5919.41% in 2023, then tumbled by -154bps to 15056.04% in 2024, then increased by 21bps to 11953.25% in 2025.
  • Business Quant data shows EBITDA Margin for CLNN at 11953.25% in Q4 2025, 58506.67% in Q3 2025, and 27244.44% in Q2 2025.